Literature DB >> 9462189

Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants.

B Jónsson1, K Tullus, A Brauner, Y Lu, G Noack.   

Abstract

AIM: To investigate if early changes in concentrations of proinflammatory cytokines in tracheobronchial aspirate fluid (TAF) from preterm infants could be used to detect infants at risk of chronic lung disease (CLD) and help in the selection of patients for early steroid treatment.
METHODS: Twenty eight preterm infants less than 34 weeks of gestation (median 26 weeks) were intubated and daily measurements of TAF concentrations of tumour necrosis factor alpha (TNF alpha) and the interleukins IL-1 beta, IL-6, and IL-8 were made, using enzyme immunoassay techniques.
RESULTS: Seventeen of the infants developed CLD. The infants who developed CLD had significantly increased concentrations of TNF alpha, IL-1 beta, IL-6 on days 2 and 3. TNF alpha, IL-6, and IL-8 concentrations were significantly related to gestational age and duration of supplemental oxygen; TNF alpha, IL-6, and IL-8 concentrations also correlated with length of time on the ventilator.
CONCLUSION: These data indicate that tracheobronchial aspirate fluid cytokine concentrations may be used as a predictor of subsequent CLD and may help select a group of preterm infants at high risk of developing CLD for early treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462189      PMCID: PMC1720706          DOI: 10.1136/fn.77.3.f198

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  24 in total

1.  Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia.

Authors:  C L Watts; A A Fanaroff; M C Bruce
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406

2.  Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.

Authors:  K Tullus; G W Noack; L G Burman; R Nilsson; B Wretlind; A Brauner
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

3.  Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes.

Authors:  J M Grigg; A Barber; M Silverman
Journal:  Am Rev Respir Dis       Date:  1992-04

Review 4.  Cytokines of the lung.

Authors:  J Kelley
Journal:  Am Rev Respir Dis       Date:  1990-03

Review 5.  The contribution of experimental models to our understanding of the pathogenesis and treatment of bronchopulmonary dysplasia.

Authors:  R A deLemos; J J Coalson
Journal:  Clin Perinatol       Date:  1992-09       Impact factor: 3.430

Review 6.  An introduction to bronchopulmonary dysplasia.

Authors:  W H Northway
Journal:  Clin Perinatol       Date:  1992-09       Impact factor: 3.430

7.  Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf).

Authors:  C P Speer; B Götze; T Curstedt; B Robertson
Journal:  Pediatr Res       Date:  1991-07       Impact factor: 3.756

8.  Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment.

Authors:  S H Murch; T T MacDonald; C B Wood; K L Costeloe
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

9.  Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.

Authors:  T A Merritt; C G Cochrane; K Holcomb; B Bohl; M Hallman; D Strayer; D K Edwards; L Gluck
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  Epidemiology and classification of acute, neonatal respiratory disorders. A prospective study.

Authors:  O Hjalmarson
Journal:  Acta Paediatr Scand       Date:  1981-11
View more
  31 in total

1.  Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia.

Authors:  Elisa Ghelfi; Cagatay Karaaslan; Sara Berkelhamer; Serra Akar; Harry Kozakewich; Sule Cataltepe
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-22       Impact factor: 6.914

2.  Iloprost attenuates hyperoxia-mediated impairment of lung development in newborn mice.

Authors:  Nelida Olave; Charitharth Vivek Lal; Brian Halloran; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-28       Impact factor: 5.464

3.  Efficacy of Leukadherin-1 in the Prevention of Hyperoxia-Induced Lung Injury in Neonatal Rats.

Authors:  Jawahar Jagarapu; Jelte Kelchtermans; Min Rong; Shaoyi Chen; Dorothy Hehre; Stefanie Hummler; Mohd Hafeez Faridi; Vineet Gupta; Shu Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

4.  Urinary ß2-microglobulin in very preterm neonates with chorioamnionitis.

Authors:  Shigeru Nishimaki; Yoshio Shima; Miho Sato; Hiromi An; Shujiro Fujita; Shiho Iwasaki; Haruko Horiguchi; Kazuo Seki; Shumpei Yokota
Journal:  Pediatr Nephrol       Date:  2011-06-11       Impact factor: 3.714

5.  Does the use of 50% oxygen at birth in preterm infants reduce lung injury?

Authors:  A E Harling; M W Beresford; G S Vince; M Bates; C W Yoxall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-29       Impact factor: 5.747

6.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Sex-specific differences in neonatal hyperoxic lung injury.

Authors:  Krithika Lingappan; Weiwu Jiang; Lihua Wang; Bhagavatula Moorthy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-24       Impact factor: 5.464

Review 8.  Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia.

Authors:  Charitharth Vivek Lal; Namasivayam Ambalavanan
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

9.  Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants.

Authors:  Carl T D'Angio; Namasivayam Ambalavanan; Waldemar A Carlo; Scott A McDonald; Kristin Skogstrand; David M Hougaard; Seetha Shankaran; Ronald N Goldberg; Richard A Ehrenkranz; Jon E Tyson; Barbara J Stoll; Abhik Das; Rosemary D Higgins
Journal:  J Pediatr       Date:  2016-04-23       Impact factor: 4.406

Review 10.  Cytokines and perinatal brain damage.

Authors:  Olaf Dammann; T Michael O'Shea
Journal:  Clin Perinatol       Date:  2008-12       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.